Vertex Pharmaceuticals Incorporated (VRTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$450.78
Day's range
$461.26

Vertex Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CAPITAL WORLD INVESTORS 08/12/2026 26.12 M $12.97 B   2.94% 10.29%
BLACKROCK, INC. 08/07/2026 24.11 M $11.98 B   0.58% 9.50%
CAPITAL RESEARCH GLOBAL INVESTORS 08/12/2026 19.49 M $9.68 B   -7.74% 7.68%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 16.58 M $8.24 B   0.41% 6.53%
STATE STREET CORP 08/07/2026 11.87 M $5.90 B   1.20% 4.68%
INVESCO LTD. 08/14/2026 8.04 M $4.00 B   50.86% 3.17%
JPMORGAN CHASE & CO 08/12/2026 6.52 M $3.26 B   -7.33% 2.57%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 6.02 M $2.98 B   -1.98% 2.37%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 4.88 M $2.42 B   -5.18% 1.92%
CAPITAL INTERNATIONAL INVESTORS 08/12/2026 4.70 M $2.33 B   -8.41% 1.85%
LOOMIS SAYLES & CO L P 08/14/2026 3.92 M $1.95 B   -2.07% 1.54%
FRANKLIN RESOURCES INC 08/13/2026 3.35 M $1.66 B   507.34% 1.32%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 3.25 M $1.61 B   1.09% 1.28%
MORGAN STANLEY 08/13/2026 3.24 M $1.61 B   1.67% 1.28%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 3.09 M $1.53 B   0.96% 1.22%
BANK OF AMERICA CORP /DE/ 08/14/2026 3.04 M $1.51 B   5.59% 1.20%
ALLIANCEBERNSTEIN L.P. 08/14/2026 3.02 M $1.35 B   -22.80% 1.19%
JENNISON ASSOCIATES LLC 08/03/2026 3.00 M $1.49 B   9.43% 1.18%
NORGES BANK 08/12/2026 2.97 M $1.48 B   100.00% 1.17%
AMERIPRISE FINANCIAL INC 08/14/2026 2.60 M $1.29 B   -1.09% 1.03%
NORTHERN TRUST CORP 08/13/2026 2.49 M $1.24 B   -3.03% 0.98%
GOLDMAN SACHS GROUP INC 08/14/2026 2.48 M $1.23 B   2.64% 0.98%
CLEARBRIDGE INVESTMENTS, LLC 08/13/2026 2.34 M $1.16 B   -13.26% 0.92%
VICTORY CAPITAL MANAGEMENT INC 08/07/2026 2.17 M $1.08 B   15.07% 0.86%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 2.04 M $1.01 B   6.27% 0.80%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 2.04 M $1.01 B   100.00% 0.80%
LEGAL & GENERAL GROUP PLC 08/14/2026 1.87 M $928.89 M   -4.38% 0.74%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.73 M $858.56 M   -1.80% 0.68%
BANK OF NEW YORK MELLON CORP 08/06/2026 1.67 M $830.84 M   5.43% 0.66%
DEUTSCHE BANK AG\ 08/07/2026 1.58 M $784.39 M   2.69% 0.62%
AMUNDI 08/11/2026 1.55 M $768.20 M   5.03% 0.61%
FMR LLC 08/13/2026 1.46 M $723.81 M   -27.87% 0.57%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.43 M $708.03 M   -2.75% 0.56%
JUPITER TOPCO LLC 08/14/2026 1.26 M $625.80 M   100.00% 0.50%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.17 M $580.70 M   18.15% 0.46%
WCM INVESTMENT MANAGEMENT, LLC 08/13/2026 1.15 M $575.64 M   2.74% 0.45%
NUVEEN, LLC 08/11/2026 1.08 M $537.30 M   -0.26% 0.43%
ROYAL BANK OF CANADA 08/14/2026 980.26 K $486.92 M   -11.84% 0.39%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 08/13/2026 897.89 K $446.04 M   5.88% 0.35%
ASSENAGON ASSET MANAGEMENT S.A. 08/21/2026 759.56 K $377.30 M   41.38% 0.30%
WELLS FARGO & COMPANY/MN 08/14/2026 749.53 K $372.31 M   0.61% 0.30%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 738.38 K $366.77 M   15.56% 0.29%
BARCLAYS PLC 08/14/2026 733.27 K $364.24 M   10.56% 0.29%
SWISS NATIONAL BANK 08/11/2026 717.44 K $356.37 M   -3.65% 0.28%
UBS GROUP AG 08/13/2026 712.26 K $353.80 M   12.95% 0.28%
CITIGROUP INC 08/03/2026 706.97 K $351.17 M   3.54% 0.28%
HSBC HOLDINGS PLC 08/14/2026 676.25 K $335.81 M   3.17% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 674.30 K $334.95 M   20.17% 0.27%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 08/07/2026 647.19 K $321.48 M   8.32% 0.25%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 616.17 K $305.00 M   260.27% 0.24%

Vertex Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 2438 institutional investors and hedge funds held shares of Vertex Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Capital World Investors: 26.12 M

BlackRock, Inc.: 24.11 M

Capital Research Global Investors: 19.49 M

VANGUARD CAPITAL MANAGEMENT LLC: 16.58 M

STATE STREET CORP: 11.87 M

Invesco Ltd.: 8.04 M

95.90% of Vertex Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 334.81 M shares in the last 24 months. This purchase volume represents approximately $154.31 B in transactions.